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Abstract
HSPB6 is a member of the human small heat shock protein (sHSP) family, a conserved group of molecular chaperones that
bind partially unfolded proteins and prevent them from aggregating. In vertebrate sHSPs the poorly structured N-terminal
domain has been implicated in both chaperone activity and the formation of higher-order oligomers. These two functionally
important properties are likely intertwined at the sequence level, complicating attempts to delineate the regions that define
them. Differing from the prototypical a-crystallins human HSPB6 has been shown to only form dimers in solution making it
more amendable to explore the determinants of chaperoning activity alone. Using a systematic and iterative deletion
strategy, we have extensively investigated the role of the N-terminal domain on the chaperone activity of this sHSP. As
determined by size-exclusion chromatography and small-angle X-ray scattering, most mutants had a dimeric structure
closely resembling that of wild-type HSPB6. The chaperone-like activity was tested using three different substrates, whereby
no single truncation, except for complete removal of the N-terminal domain, showed full loss of activity, pointing to the
presence of multiple sites for binding unfolding proteins. Intriguingly, we found that the stretch encompassing residues 31
to 35, which is nearly fully conserved across vertebrate sHSPs, acts as a negative regulator of activity, as its deletion greatly
enhanced chaperoning capability. Further single point mutational analysis revealed an interplay between the highly
conserved residues Q31 and F33 in fine-tuning its function.
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Introduction
Acting as ATP-independent molecular chaperones, small heat
shock proteins (sHSPs) play an important role in protein house-
keeping [1–3]. These proteins, found in all kingdoms of life,
function by binding partially unfolded protein species keeping
them in a soluble state [4]. As their name suggests, their expression
levels respond to environmental stress but some members are also
produced constitutively at high levels [5]. sHSPs are regarded as
the first-line of defense for a cell dealing with aberrant protein
species and work in concert with the other chaperone families to
maintain cellular proteostasis [6–8]. Besides their function in the
protein quality control network, members of this family also
display distinct roles in a variety of cellular pathways and
biological processes [9].
All sHSPs share the same structural arrangement consisting of a
conserved region of approximately 90 residues, called the a-
crystallin domain (ACD), flanked by unstructured N- and C-
terminal arms that vary in sequence and length [10]. The ACD
has a b-sandwich fold that is capable of dimerization. These ACD-
mediated dimers are considered to be the basic building blocks of
the higher-order oligomers generally associated with this family of
proteins [1,9,11]. While predicted to be unstructured, the N- and
C-terminal domains are necessary for oligomer formation [12–14].
In vertebrates these oligomeric assemblies are typically polydis-
perse in subunit number and shape, and at physiological
temperatures show a high turnover of the individual subunits
[15–18]. The exact mechanism of chaperone action is not fully
understood, however the general hypothesis is that sHSPs can bind
unfolding proteins via exposed hydrophobic surfaces, thereby
creating a ‘‘kinetic partitioning’’ [1] where the substrate binds the
hydrophobic sites on the sHSP rather than interacting with other
metastable species [1,11]. Some models have proposed a
mechanism where the recognition of partially unfolded proteins
or heat stress leads to the dissociation of the oligomers, releasing
dimers that can capture non-native proteins. These smaller
subunits then reassemble into the oligomer forming larger
sHSP:client protein complexes [11].
A number of studies have been conducted to pinpoint the
sequence-specific epitopes that define sHSP chaperone activity,
and the majority support a central role for the N-terminal domain
(NTD). These analyses have primarily focused on the canonical
members of the sHSP-family: the a-crystallins and HSPB1
[12,13,19–21]. Comparative analysis suggests that different
regions of the NTD are involved in chaperone activity, with some
studies reporting contradictory results [12,20,22]. These ambigu-
ities can be ascribed to the species origin of the sHSP as the NTD
is often purported to be poorly conserved. However sequence
analysis of vertebrate sHSPs show that orthologues from distantly
related species share high similarity (Fig. S1). Although paralogues
within a single species demonstrate more sequence divergence, the
NTD contains a highly conserved region (Fig. 1A and Fig. S1) and
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comparative genome analysis suggests an overall strong amino
acid bias amongst vertebrate sHSPs (Fig. 1B) [10]. Likely more
crucial to the observed differences is the overlapping role of the
NTD in both chaperoning and higher-order assembly
[12,13,19,22]. This dual function makes it difficult to separate
the effect of mutation on either property alone.
In this study we have determined the specific regions required
for chaperoning in human HSPB6 (Hsp20). Rat HSPB6 was
originally described to be a poor chaperone [23], but more recent
studies have shown that the human orthologue has equivalent
activity to aB-crystallin [24]. Importantly, in solution, human
HSPB6 only forms dimers [24,25] that possibly represent the basic
chaperoning active subspecies of all sHSP family members. Recent
efforts have led to a partial atomic structure of fragments of the rat
and human HSPB6, and by using a combination of crystallogra-
phy and small-angle X-ray scattering (SAXS), a solution model for
the full-length protein composed of the ACD-based dimer with
exposed but compact N-termini has been proposed [25,26].
Although the protein shows the propensity to transiently self-
associate, even at high concentrations the formation of a higher-
order oligomeric assembly has not been observed [25,27,28]. This
inability to form oligomers occurs despite the NTD showing
similar sequence length and properties to the a-crystallins (Fig. 1A
and Fig. S1). HSPB6 is thus an excellent candidate for studies on
elucidating the role of the NTD in defining chaperone-like activity.
Experimental Procedures
Mutagenesis and cloning
The previously described small ubiquitin modifier (SUMO)-
fusion of HSPB6 [28] was used as a template for the generation of
the different deletion constructs and point mutants. All 10 amino
acid N-terminal deletions (Fig. 2A) were generated using whole
plasmid amplification, where one primer contained an extension
of sequence complementary to the other (Table S1). Point
mutations were created using Quickchange mutagenesis. DpnI-
treated PCR products were transformed into E. coli NEB5a (New
England Biolabs) and positive clones were verified by sequencing.
Figure 1. Properties of the N-terminal domain of HSPB6. (A) Multiple sequence alignment of the NTD of HSPB6 with other human sHSPs, the
a-crystallins from Danio rerio (CRYAA and CRYAB) and two related proteins from Drosophila melanogaster (l(2)_efl and Hsp27). The two highly
conserved residues that are mutated in this work are indicated by arrowheads. The alignment was made using Aline [54]. Uniprot accession numbers:
HSPB1 (Hsp27): P04792, HSPB2: Q16082, HSPB4 (CRYAA): P02489, HSPB5 (CRYAB): P02511, HSPB6: O14558, HSPB8: Q9UJY1, CRYAA_Danre: Q8UUZ6,
CRYAB_Danre: Q9PUR2, Hsp27_Drome: P02518, l(2)efl_Drome: P82147. (B) Amino acid composition within the N-terminus of HSPB1, HSPB2, HSPB4,
HSPB5, HSPB6 and HSPB8 and orthologues in different species (H. sapiens, B. taurus, M. musculus, X. leavis or tropicalis, G. gallus and D. rerio). The
average amino acid composition is shown as white bars, HSPB6 amino acid composition is shown as black bars. (C–D) Chaperone-like activity of
human HSPB6 and the N-terminal deletion construct (DN) using insulin (C) and yADH (D) as substrates. The monomer mass molar ratios of
substrate:sHSP were 1:0.2 and 1:2 respectively, and were the same as used in further experiments. Curve 1, substrate alone; 2, substrate + DTT; 3, with
addition of HSPB6; 4, with addition of DN.
doi:10.1371/journal.pone.0105892.g001
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HSPB6 variants DN, DN11 and HSPB4 were created using the In-
Fusion cloning kit (Clontech) into pETHSUL [29]. The template
sequence for HSPB4 amplification was pANT7-cGST. HSPB4
obtained from the DNASU plasmid repository [30]. The full-
length HSPB1 expression construct was described previously [28].
All constructs were designed such that, upon cleavage of the
linearly fused SUMO chimera with recombinant SUMO-hydro-
lase, no additional non-native residues would be present on the
target protein.
Expression and purification
All constructs were over-expressed in the E. coli NiCo21 (DE3)
strain (New England Biolabs) containing pRARE2 (EMD Biosci-
ences). Transformed clones were cultured in ZYP-5052 auto-
inducing medium [31] using described conditions [28]. Lysis,
clarification and subtractive immobilized metal affinity chroma-
tography (IMAC) of the SUMO-fusions were carried out as
reported previously [29]. Following the initial isolation steps all
proteins were dialyzed to 20 mM Tris-HCl pH 7.0, containing
2.5 mM DTT and 10% w/v glycerol and further purified by
anion-exchange chromatography loading the sample onto a
HiTrap HP Q column (GE Healthcare). The bound protein was
eluted using a linear gradient from 0 to 200 mM NaCl in 20 mM
Tris-HCl, pH 7.0 and 2.5 mM DTT over 20 column volumes.
Pooled fractions were concentrated and additionally purified by
size exclusion chromatography (SEC) using a Superdex 200 16/60
PG column (GE Healthcare) equilibrated in 50 mM sodium
phosphate pH 7.5, 100 mM NaCl. For HSPB1 and HSPB4 the
same protocol was followed except for the final SEC step, which
was performed in the same buffer complemented with 2.5 mM
DTT. All purification steps were carried out at 4uC. Protein
fractions were checked by SDS-PAGE, pure samples were pooled
together and concentrated to approximately 20 mg/ml. Aliquots
of purified protein were flash-frozen in liquid nitrogen and stored
at 280uC until required.
Analytical SEC
The various HSPB6 constructs were examined by analytical
SEC at 4uC. 100 ml samples of each construct at a concentration
of 2.5, 5 and 10 mg/ml were loaded onto a Superdex 200 10/300
GL column (GE Healthcare) pre-equilibrated in 25 mM HEPES
pH 7.5, 150 mM NaCl and 2.5 mM DTT. The frozen protein
aliquots were thawed and diluted in 50 mM sodium phosphate,
100 mM NaCl, pH 7.5 complemented with 10 mM DTT. After
incubation for 20 minutes on ice, samples were centrifuged at 4uC
for 10 min at 14200 g prior to loading. The DN11-construct of
HSPB6 was not analyzed on SEC as this construct could not be
concentrated above 5 mg/ml. Column calibration was performed
using the Molecular Weight Calibration Kit from GE Healthcare.
Small-angle X-ray studies
SAXS data were collected at the SWING beamline (Soleil
Synchrotron, Saint-Aubin, France) with an inline HPLC system.
The purified concentrated proteins were thawed and their
concentrations were measured with a Nanodrop spectrophotom-
eter (Thermo Scientific) using their theoretical specific absorption
coefficient. A 200 ml sample was prepared containing 5 mg/ml of
HSPB6 by diluting the concentrated sample with column buffer
(20 mM HEPES, 150 mM NaCl, pH 7.4 and 2.5 mM DTT). The
other constructs were prepared in the same manner to yield
equivalent molarity. Immediately prior to SAXS measurement,
the samples were centrifuged at 14200 g at 4uC for 10 min. 75 ml
of each sample was loaded onto a Shodex KW404-4F column pre-
equilibrated in the column buffer with a flow-rate of 0.2 ml/min at
20uC, for the DN11-construct 111 ml of a 3.37 mg/ml solution
was loaded as this protein could not be concentrated above this
value. During each HPLC run, SAXS data for both buffer and
protein were collected. For the buffer 100 frames were collected
starting 5 min after injection with an exposure time of 0.75 s and
dead time of 1 s. 250 frames were collected for the protein starting
after 16 min using the same exposure and dead times. Buffer
frames were processed, averaged and subtracted from each protein
frame using Foxtrot (software available on site at SWING-
beamline). The radius of gyration (Rg) and forward scattering (I0)
were calculated for each buffer subtracted protein curve using
AutoRg [32], with data that had been averaged using a ten frame
moving average algorithm to improve the signal-to-noise ratio. For
each sample ten scattering curves, collected around the peak
maximum, were averaged and then scaled to the curve with the
maximum forward scattering value (I0). These averaged curves
were used for further analysis. The Rg and I0 were calculated in
PRIMUS using both AutoRg and GNOM and the volumes of the
scattering particles were determined using DATPOROD, avail-
able in the Atsas-package [32]. The molecular weight of each
protein was determined on an absolute scale using the I0 of water
[33], as well as based on the Porod volume using a protein density
of 0.588 Da/A˚3 [32].
Bis-ANS binding studies
A stock solution of bis-ANS (4,49-Dianilino-1,19-binaphthyl-
5,59-disulfonic acid, Sigma) was prepared in 95% ethanol and the
concentration was determined by measuring the absorbance of a
1:10 dilution in water at 385 nm using an extinction coefficient of
16790 M21 cm21. Serial dilutions of the bis-ANS stock, with a
ten-fold higher concentration than final target value were freshly
prepared in 95% ethanol to ensure that the final amount of
ethanol present in each sample remained constant (10% of final
volume). The binding assay was performed at room temperature
using 0.04 mg/ml (equivalent to 2.5 mM) of each protein construct
diluted in 50 mM sodium phosphate pH 7.5, 100 mM NaCl and
5 mM DTT and mixed with increasing amounts of bis-ANS with
a total volume of 150 ml. Fluorescence was measured in a 96-well
black, flat-bottom polypropylene plate (Greiner BioOne) on an
Infinite M200 fluorescence plate reader (Tecan Instruments). The
solutions were excited at 390 nm and emission intensities were
measured at 490 nm, the photomultiplier settings were set at an
optimal gain to ensure highest sensitivity. All values are measured
Figure 2. N-terminal 10-residue deletion mutants. Cartoon of the
different HSPB6 constructs used in this work. The a-crystallin domain
(ACD) is shown in grey. The numbers at the top of the cartoon
correspond to the residue number at domain boundaries.
doi:10.1371/journal.pone.0105892.g002
Mapping Determinants of Chaperone Activity Using a Dimeric sHSP
PLOS ONE | www.plosone.org 3 August 2014 | Volume 9 | Issue 8 | e105892
in arbitrary units and were normalized to those determined for bis-
ANS binding to HSPB6. All values were corrected for the
fluorescence from bis-ANS alone and each measurement was
performed in triplicate.
Chaperone assays
Human recombinant insulin (Sigma) was dissolved in 2.5%
acetic acid, hen egg white lysozyme (HEWL, Sigma) and
recombinant yeast alcohol dehydrogenase (yADH, Sigma) were
dissolved 50 mM sodium phosphate, 100 mM NaCl, pH 7.5 at a
concentration of approximately 5 to 10 mg/ml. All substrate
proteins were dialyzed overnight at 4uC using SpectraPor Dialysis
membrane with a 3 kDa molecular weight cut-off (MWCO,
SpectrumLabs) into 50 mM sodium phosphate, 100 mM NaCl,
pH 7.5. HSPB6 and its mutants were thawed and if necessary also
dialyzed overnight at 4uC against the same buffer using Slide-A-
Lyzer mini dialysis unit with a 3 kDa MWCO (Thermo Scientific).
The concentration of each protein, including the substrates was
determined using a Nanodrop spectrophotometer (Thermo
Scientific). The substrate protein was added to assay buffer to
yield a final concentration of 0.25 mg/ml and sHSP was added to
give different molar ratios (substrate:sHSP). The mixture contain-
ing substrate and sHSP was allowed to incubate for 20 minutes at
room temperature. Aggregation of insulin and HEWL was
induced by the addition of 10 mM of DTT (final concentration)
in 50 mM sodium phosphate and 100 mM NaCl to the pre-
incubated assay mixture. To induce aggregation of yADH, the
sample was heated to 42uC in presence of 20 mM DTT and
2 mM EDTA. All assays were performed in a final volume of
180 ml in a 96-well, flat-bottom, half-area UV-transparent plate
(UV-Star, Greiner Bio-one). Aggregation was followed by mon-
itoring light scattering at 340 nm in an ELx808IU plate reader
(Biotek) at 37uC (insulin and lysozyme) or 42uC (yADH) for
90 min. The optical density was measured each minute and
blanked to the buffer. The chaperone activity was defined as the
percentage protection, where the absorbance at 340 nm of
substrate alone (without DTT) was taken as 100%, and the
absorbance of the substrate with DTT after 90 minutes as 0%.
Each condition was performed in triplicate.
Dynamic light scattering studies
DLS measurements were performed on HSPB6 alone and on
the mixture containing insulin and HSPB6 after DTT-induced
aggregation. For HSPB6, a 1 mg/ml solution was made in 50 mM
sodium phosphate, 100 mM NaCl and 2.5 mM DTT, pH 7.5. For
the mixture of insulin:sHSP, 0.25 mg/ml insulin was incubated
with wild type HSPB6 or D31–40 in the same monomer molar
ratio as in the chaperone assays. After incubation at 37uC for
90 min, the scattered light was measured using a Zetasizer mV
(Malvern Instruments) in a 12 ml cuvette, with automatic
measurement duration. Data analysis was performed using the
Zetasizer Software (Malvern Instruments) and for all samples a
refractive index of 1.450 and a viscosity of 0.7451 cP were used.
The intensity-weighted value of the mean molecular size (Z-
average) was determined by single cumulant fitting of the decay
function, which yielded an estimate of the hydrodynamic radius
(Rh). The molecular weight (Mw) was estimated from the
hydrodynamic radius using the equation:
Rh~0:691776|M
0:392
w
where Rh is in nm and Mw is in KDa [34].
Results
Expression and purification of HSPB6 deletion mutants
The NTD of vertebrate sHSPs has previously been described as
a determinant of chaperoning activity. To verify the importance of
this region for human HSPB6– corresponding to the first 70 amino
acids (Fig. 1A and Fig. S1) – we have cloned and expressed a
construct termed DN, which was completely missing this region.
At equivalent monomer molar concentrations to the full-length
protein, DN failed to prevent DTT-induced aggregation of human
insulin and yeast alcohol dehydrogenase (yADH) (Fig. 1C and D)
despite showing similar thermal stability as the full-length protein
(Fig. S5). Thus, the NTD of HSPB6 is essential for chaperone
activity at least for the two substrates tested.
To further delineate the sequence motifs within the NTD that
are important for activity, we cloned and successfully expressed
seven additional HSPB6 constructs, with systematic 10 amino acid
deletions covering the whole NTD (Fig. 2A). All constructs, except
DN10, gave suitable yields of pure protein for biochemical and
biophysical characterization (Fig. S2). Showing equivalent solubil-
ity to the wild-type protein, all could be readily concentrated
above 25 mg/ml.
In the case of the DN10 construct, the SUMO fusion expressed
well and could be purified by IMAC, but the protein precipitated
during digestion of the fusion with recombinant SUMO hydrolase.
As this construct, after proteolytic cleavage, begins with the sole
tryptophan found in HSPB6 (Fig. 1A), we created a longer
truncation termed DN11, that removed this hydrophobic residue.
Even though this truncation showed some precipitation upon
concentration, it did display higher solubility than DN10, and
could be concentrated to approximately 4 mg/ml. The poor
solubility of these two constructs contrasts markedly with the
behavior of the full-length protein and the other deletion variants.
Interestingly, in a previous study [25] an even longer N-terminal
deletion construct, where the first 23 amino acids of HSPB6 were
deleted showed solubility equivalent to the full-length protein.
This, in combination with the fact that the DN11–20 also behaved
well, suggests that the poor solubility observed for both DN10 and
DN11 can be ascribed to residues 12 to 22. Surprisingly this region
contains two arginines and a limited number of small hydrophobic
residues that alone cannot explain the observed reduction in
solubility (Fig. 1A).
Biophysical characterization of HSPB6 and truncations
The oligomeric size and the self-association properties of the
various HSPB6 constructs were assessed by SEC using a Superdex
200 GL column. For the wild type protein and all 10-residue
deletions, the SEC profile contained a single elution peak, which
corresponded to a radically smaller species compared to the
HSPB1 oligomer (apparent mass 800 kDa, Fig. 3).
Notably the elution peak for HSPB6 shifted towards smaller
elution volumes upon increase of the loaded sample concentration,
corresponding to an increase of the apparent molecular weight
(Fig. 4A, Table 1) [25,27]. This shift in the elution volume cannot
be explained by the formation of larger assemblies, as one would
then expect additional distinct peaks in the chromatogram, but
rather by non-ideal associative behavior resulting from attractive
forces between the individual protein molecules. With the
exception of D31–40, all other 10-residue deletion constructs also
displayed the capacity to self-associate (Table 1). For the former
construct, the peak maxima position remained the same for all
three concentrations tested (Fig. 4A).
Despite the non-ideal behavior, the elution volumes for all
constructs at the lowest loaded concentration were very similar,
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suggesting the same molecular weight (Fig. 3). The D61–70
construct however, was more polydisperse (based on peak width
at half height), slightly bigger when compared to the wild-type
protein at the lowest concentration, and showed a larger increase
in size upon increasing concentration (Fig. 4A and Table 1). For
this single construct the more pronounced shift in size suggests the
possibility of the presence of higher-order structures, albeit still
much smaller than the HSPB1 oligomers (Fig. 3).
To further investigate the effect of the truncations on the
structure of HSPB6, small angle X-ray scattering experiments
were performed on a set-up with an inline HPLC-system. For the
wild-type protein and all truncations, 250 scattering frames were
collected at a single loaded concentration during peak elution from
the column. Guinier analysis was performed on each buffer
subtracted, radially averaged frame to calculate the radius of
gyration (Rg) and forward scattering (I0). These values were plotted
against the frame number to create a SAXS-based elution profile
(Fig. 5). The normalized I0 values, determined on an absolute
scale by calibration with water, correspond to the mass of the
scattering species. For all constructs, except D61–70, the
normalized I0 at the peak maximum was close to that of the
full-length protein with a value of 0.02. Calculation of the
molecular weight for each construct, either by using the measured
I0 values at the peak maxima or based on determination of the
Porod volume from the averaged SAXS curve at the same point,
consistently yielded a mass close to a dimer for all samples, with
the exception of D61–70 (Table 2). This latter construct had a
calculated molecular weight closer to a tetramer, agreeing with the
SEC analysis that it forms slightly larger assemblies. For full-length
HSPB6 the SAXS-based Rg values vary from approximately 28 A˚
to 25 A˚ for the frames that have an I0 value above the peak half
height, with an Rg of 27.5 A˚ at the peak maximum (Table 2).
Similarly, the majority of the constructs had an Rg of approxi-
mately 27 A˚ at their peak maxima, suggesting there are no
significant changes in shape when compared to the full-length
protein (Fig. 5 and Table 2). The biggest Rg difference across the
elution peak was observed for DN11, with a decrease from 36 to
28 A˚. This construct also showed a double peak based on the
intensity at the zero scattering angle with a continually decreasing
Rg, confirming the aggregating behavior of this construct,
nonetheless the I0 and calculated Rg of the soluble fraction still
suggest a dimeric structure for this construct. The calculated Rg for
D61–70 of 33 A˚ is also bigger than that of the full-length HSPB6,
although the difference across the peak for the frames with an I0-
value above half-maxima was the same. This again supports the
interpretation that this construct forms slightly larger oligomeric
assemblies at an equivalent concentration to the others.
Comparison of the shape of the averaged SAXS curves at the
elution peak maxima (Fig. S3, top row) suggested that none of the
truncations underwent major structural changes relative to the
full-length protein. For all constructs analysis of the dimensionless
Kratky plots (Fig. S3, bottom row) showed the same features as
present for the wild type protein: a parabolic curve, signifying the
presence of a folded domain, followed by a slightly elevated
baseline at higher q.Rg values. In almost all cases the position and
height of the peak maxima (2.2, 1.3) was similar. These values are
higher than that expected for an ideal sphere (!3, 1.1 and Fig. S3),
suggesting a more extended structure [35]. This data is in good
agreement with a recently proposed model of HSPB6 composed of
the core ACD dimer with an ensemble of partially extended N-
terminal arms [25], and further supports the conclusion that the
deletions do not affect the overall structure of the protein. Only
DN11 showed a maximum at higher qNRg, when compared to full-
length HSPB6, which could be anticipated from the SEC data and
Rg calculation, and again might be a result from its aggregating
propensity.
Finally the same conclusions can be inferred by the pair
distribution functions (Fig. S3, middle row). All plots showed an
asymmetric peak, suggesting a slightly elongated structure [36],
with most distances centered at 27 A˚. With the exception of DN11
and D61–70, the truncations all have a Dmax of approximately 95
A˚. These values are similar to the wild type protein again
suggesting no major changes in the structure for the majority of
constructs.
Figure 3. Analytical SEC of the HSPB6 10-residue deletion
mutants and HSPB1. 100 ml of each protein at 10 mg/ml was loaded
on a Superdex 200 10/300 column at 4uC equilibrated in 25 mM HEPES,
150 mM NaCl and 2.5 mM DTT at pH 7.5.
doi:10.1371/journal.pone.0105892.g003
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Figure 4. Solution properties of the HSPB6 10-residue deletion mutants. (A) Size-exclusion chromatography profiles of wild-type HSPB6,
D31–40 and D61–70. 100 ml of protein at three different concentrations was loaded on a Superdex 200 10/300 GL column. 2.5 mg/ml is depicted as a
solid line, 5 mg/ml as a dashed line and 10 mg/ml as a dotted line. The absorbance was normalized to the maximum absorbance for each curve. (B)
Bis-ANS titration curves for HSPB1, HSPB6 and HSPB4. 2.5 mM protein was mixed with increasing concentrations of bis-ANS and fluorescence intensity
was recorded at 490 nm using an excitation wavelength of 390 nm. HSPB6 is shown in yellow, HSPB1 in black and HSPB4 in grey. (C) Bis-ANS titration
curves for all constructs, the same setup as for HSPB1 and HSPB4 was used. HSPB6 is shown in yellow, DN11 in blue, D11–20 in cyan, D21–30 in red,
D31–40 in green, D41–50 in orange, D51–60 in pink and D61–70 in violet.
doi:10.1371/journal.pone.0105892.g004
Table 1. Biophysical properties of wild-type HSPB6 and its mutants.
Construct
Concentration dependence
of apparent MWa
(kDa/(mg/ml))
Hydropathy of
the NTDb
WT 1.51 0.167
DN11 N/A 0.137
D11–20 0.81 0.209
D21–30 1.29 0.172
D31–40 –0.14 0.194
D41–50 1.92 0.128
D51–60 0.31 0.171
D61–70 3.40 0.147
D31–35 –0.01 0.218
D36–40 1.80 0.142
Q31A 1.10 0.188
Q31L 1.87 0.194
F33A –0.21 0.159
F33Y 0.42 0.154
aSlope of a linear fit of the calculated MW (determined from calibration with the Molecular Weight kit from GE Healthcare) at three different concentrations.
bCalculated as the average over the NTD using the hydrophobicity scale according to Eisenberg et al. [53].
doi:10.1371/journal.pone.0105892.t001
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Bis-ANS binding
To study the relative hydrophobicity of the different HSPB6
truncations, and its possible correlation with chaperone activity,
the binding properties of the environmental probe bis-ANS were
investigated. The full-length protein showed a linear increase in
fluorescence with increasing bis-ANS concentration but no
obvious saturation in association over the concentration range
tested (Fig. 4B and C). This behavior contrasts with human
Figure 5. SAXS analysis of the HSPB6 10-residue deletion mutants. For each construct, 250 frames were collected during elution from a
Shodex KW-404F column. The radius of gyration (Rg) and forward scattering (I0) were calculated at each measured point using buffer subtracted
scattering curves that had been averaged by a ten-frame moving average algorithm to improve the signal-to-noise. The forward scattering values are
normalized by dividing the values by the concentration of the sample at the peak maximum. The Rg is plotted as a black cross for each construct and
scaled on the left axis, the I0 is shown as a red circle and scaled on the right axis.
doi:10.1371/journal.pone.0105892.g005
Table 2. SAXS data analysis.
Construct Estimated MW (kDa)
Calculated number
of subunits Rg (A˚)
Concentration
(mg/ml)a
based on I0 of water based on Porod volume
WT 31.4 38.1 2.2 27.561.8 0.61
DN11 31.2 39.9 2.5 31.962.8 0.65
D11–20 25.7 29.5 1.8 25.261.1 0.47
D21–30 32.8 35.9 2.2 28.760.7 0.89
D31–40 28.2 32.9 2.0 26.762.2 0.79
D41–50 34.8 36.6 2.3 28.260.7 0.88
D51–60 28.3 30.8 1.9 27.361.3 0.87
D61–70 51.6 56.0 3.5 33.460.5 0.77
D31–35 30.9 35.3 2.2 27.461.3 0.97
Q31A 67.4 71.2 4.2 37.560.8 1.37
Q31L 64.7 72.9 4.3 38.061.2 1.31
F33A 29.4 38.4 2.3 30.261.0 2.32
F33Y 36.8 42.6 1.9 30.961.6 1.77
aThe concentration for each construct at the peak maximum was calculated using the maximum absorbance at 280 nm as it eluted from the column and their
calculated absorbance coefficients.
doi:10.1371/journal.pone.0105892.t002
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HSPB1 and HSPB4 - two sHSPs that form large oligomeric
species - both of which show a typical hyperbolic curve (Fig. 4B).
The difference can be explained by the fact that the large
oligomers of HSPB1 and HSPB4 contain an accessible solvent-free
hydrophobic core with high affinity for bis-ANS. On the contrary
the HSPB6 dimers bind bis-ANS with a reduced affinity due to the
absence of such a structure. The same phenomenon has been
observed for human HSPB8, a potent chaperone which also only
forms small oligomeric species in solution [37].
For all the truncations the bis-ANS titration profiles were more
similar to the full-length HSPB6 than that of HSPB1 and HSPB4
(Fig. 4B and C), suggesting that none of deletions resulted in a
large alteration in affinity. In comparison to the other constructs
D11–20 and D51–60 demonstrated a lower final fluorescence.
Although this indicates a reduced hydrophobicity, the calculated
hydropathy of the NTD of these two deletions was conversely
higher than that of the full-length protein (Table 1), due to the
removal of arginine residues in both cases (Fig. 1A). Even though
bis-ANS is a probe for a hydrophobic environment, it has been
recognized that the negatively charged sulfate groups might
interact with arginines on proteins that are in close proximity to
hydrophobic patches and result in enhanced bis-ANS fluorescence
[38]. Thus the reduction in fluorescence in these two deletion
constructs may be explained purely by the removal of these
residues.
Three constructs DN11, D31–40 and D61–70 do appear to
reach a plateau with increasing bis-ANS concentration suggesting
an increased affinity for this probe when compared to the full-
length protein. For DN11 and D61–70 this is likely due to the
higher propensity of the former to aggregate and the latter to
reversibly associate in solution (Fig. 4 and 5), both phenomena
possibly yielding structures containing a more apolar environment.
In the case of D31–40, which showed no concentration dependent
effect on elution volume (Fig. 4A), this can be explained by the loss
of a number of charged residues in this region (Fig. 1A).
Chaperone activity of HSPB6 and deletions
Concluding that deletion mutants did not result in a major
structural change, the chaperone activity of each was compared to
full-length HSPB6 using insulin, yADH and hen egg white
lysozyme as substrates (Fig. 6 and Fig. S5). For all three proteins,
aggregation could be readily induced by reduction of the disulfide
bonds. Under the same conditions all HSPB6 constructs were
stable on their own (Fig. S5, J–K). For DN11 the chaperone-like
activity was determined despite its propensity to aggregate at
concentrations above 5 mg/ml. The concentrations used in the
assays were below the solubility limit for this construct, and results
from our biophysical characterization show that the soluble
fraction has a similar structure and oligomeric state as HSPB6.
As opposed to the full NTD deletion, the smaller deletions all
showed some capacity to protect insulin from aggregation, even at
a four-fold lower concentration (Fig. 6A). Both DN11 and D61–70,
the deletion mutants corresponding to the two ends of the NTD,
demonstrate activities similar to the WT protein (Fig. 6A). Four
constructs D11–20, D21–30, D41–50 and D51–60 showed, on
average, a 50% decrease in the ability to protect insulin against
aggregation at all substrate:sHSP ratios tested (Fig. 6A). Intrigu-
ingly D31–40, the region found in center of the NTD,
demonstrated nearly 100% protection at all substrate:chaperone
ratios tested, thus displaying an approximate five-fold increase in
chaperone activity relative to wild-type HSPB6. For all constructs
the change in the protective capacity manifested itself purely in the
final value of the absorbing species, with no obvious change in the
length of the lag phase following the addition of the reducing agent
(Fig. S5, A–C). This suggests that there is little to no effect on the
unfolding, but only on the subsequent aggregation of the protein.
Using yADH as a substrate resulted in a slightly different
chaperoning profile (Fig. 6B). In this case only DN11, D41–50 and
D51–60 proved less effective in protecting against aggregation.
Importantly however, D31–40 demonstrated the same increase in
Figure 6. Chaperone-like activity of HSPB6 and the 10-residue
deletion mutants. Aggregation was monitored by following the
absorbance at 340 nm for 90 min. The percentage protection for each
construct was calculated as described in the Materials and Methods. (A)
0.25 mg/ml insulin used as a substrate. Aggregation was induced by
adding a final concentration of 10 mM DTT prior to continuous
measurement at 37uC. The ratios of substrate to sHSP are 1:0.2 (black),
1:0.1 (gray) and 1:0.05 (light gray) (B) 0.25 mg/ml yADH used as a
substrate. Aggregation was induced by adding 20 mM DTT and 2 mM
EDTA (final concentration) prior to measurement at 42uC. The monomer
mass molar ratios of substrate to sHSP were 1:2 (black), 1:1 (gray) and
1:0.5 (light gray). (C) DTT-induced aggregation of HEWL in absence and
presence of HSPB6 and the truncations. For clarity not all constructs are
shown. The monomer mass molar ratio of HEWL:sHSP was 1:2.
doi:10.1371/journal.pone.0105892.g006
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the ability to chaperone compared to the wild-type as in the
experiments with insulin as a substrate (Fig. 6B). All the remaining
constructs showed near wild-type activity. Similar to the time-
dependent aggregation profiles using insulin as a substrate, no
HSPB6 deletion altered the length of the lag phase before
detectable yADH aggregation was observed (Fig. S5, D–F). The
overall ability of HSPB6 and its deletion mutants was lower when
compared to the assay with insulin. The highest protection level
was approximately 70% for wild type HSPB6 against yADH,
whereas it was around 90% in chaperoning insulin. It should be
noted that for both substrates the ratio of substrate:sHSP was
different: for insulin the highest monomer molar ratio was 1:0.2,
leading to a 5-fold molar excess of insulin, whereas for yADH this
was 1:2, leading to a 2-fold molar excess of sHSP. These ratios
were based on previous publications where a 1:1 weight ratio
seems sufficient for full protection of a substrate protein [1,24] and
also empirically determined. They were chosen to have a
measurable protection level at the highest ratio and a concentra-
tion dependent decrease in activity with lower ratios.
In stark contrast to the insulin and yADH chaperone assays, all
constructs, including the full-length HSPB6 resulted in an increase
in the final absorbance of the scattering species when incubated
with reduced HEWL (Fig. 6C). Lowering the amount of the sHSP
construct used in the assay led to a reduction in the absorbing
species (Fig. S5, G–I) suggesting that HSPB6, and the different
deletion constructs co-aggregate with the substrate. This was also
confirmed by SDS-PAGE (results not shown). Even so, the
constructs that showed lower protective capacity in the assays with
both insulin and yADH (D41–50 and D51–60), resulted in a lower
final absorbance with HEWL (Fig. 6C and Fig. S5, G–I). Similarly
the more active D31–40 deletion construct resulted in slightly
higher levels of aggregation.
With insulin as the smallest substrate used (5.8 kDa), we
investigated the size of the resulting solution species 90 min after
addition of DTT, with and without HSPB6, using dynamic light
scattering (DLS) (Table 3). Using a single exponential fitting
regime, reduced insulin alone showed a highly polydisperse peak
with a hydrodynamic radius centered at 1600 nm. In the presence
of both HSPB6 and the activating deletion D31–40, the average
hydrodynamic radius of the scattering species was dramatically
reduced to 28 nm and 23 nm respectively, albeit with an
equivalent percentage polydispersity. Thus the data clearly show
that HSPB6 inhibits the formation of large amorphous aggregates
maintaining insulin in a smaller and more soluble state. These
latter species though are bigger than the two HSPB6 constructs
tested alone, with an estimated molecular weight of the chaperone-
substrate complex in the order of a few MDa. These large
polydisperse complexes are equivalent in size to those seen for the
a-crystallins with the same substrate [39,40].
As it is the B-chain of insulin that is actually the insoluble
component upon reduction [41] the average monomer weight
ratio of sHSP and substrate in the soluble complex would be
approximately 1:1 assuming full binding at the 1:0.2 insulin:sHSP
ratio. These complexes would therefore be comprised of approx-
imately 5 insulin B-chain molecules per sHSP and agree with
previous observations where sHSPs seem to be capable in
solubilizing their own weight [1].
In summary, there appears to be no site within the NTD that
solely defines chaperoning ability, as all the truncations demon-
strated some capacity to protect the tested substrates against
aggregation. However, for all three substrates tested, deletion of
residues 41–60 do show a marked reduction in chaperoning
capacity, an observation also seen form residues 21–30 with insulin
and HEWL, suggesting their possible importance in this role. Most
intriguing is the increased activity of the 31–40 deletion. This
region of HSPB6 is highly conserved in both human and distantly
related species orthologues (Fig. 1A and Fig. S1), a finding that
suggests a conserved role as a negative regulator of chaperone
activity.
Refined mapping of the 31–40 region
In order to further investigate the role of residues 31–40 in
defining HSPB6 chaperoning activity, two smaller five amino acid
deletions (D31–35 and D36–40) were generated. Analytical SEC
showed that the D31–35 construct mimics the behavior of the
larger D31–40 deletion, showing ideal solution properties
(Fig. 7A). Conversely D36–40 behaved like the wild-type protein
(Fig. 7A). Again, no larger oligomeric species were observed for
the two constructs at the three loaded concentrations suggesting
that they are dimers in solution like the wild-type protein (data not
shown). This was confirmed by SEC-coupled SAXS for the D31–
35 construct. This deletion showed a stable Rg of 28 A˚ across the
elution peak and had a calculated mass of 35 kDa (Table 2,
Fig. 7B). This value is equivalent to the expected dimer
(theoretical weight 33 kDa).
Bis-ANS binding studies of the two smaller deletions showed
that both had a similar hydrophobicity when compared to the full-
length protein (Fig. 7C). Even though the calculated hydropathy
values suggested a higher hydrophobicity for the D31–35 construct
(Table 1), we could not distinguish a clear difference with the wild
type protein. This again can be due to the fact that, relative to
HSPB1 and HSPB4, the NTD is solvent-exposed, thus any
expected differences in hydrophobicity due to modifications of this
domain will be minor when measured by this probe.
Assessment of the chaperone-like activity using insulin and
yADH as substrates revealed that the region encompassing
residues 31 to 35 is responsible for the negative regulatory effect
seen in the larger D31–40 deletion (Fig. 7D and E, Fig. S6). For
insulin the protection levels of both constructs were again higher
than when using yADH as a substrate. Curiously, the D36–40
construct, which showed elevated activity when compared to wild
type HSPB6 with insulin – most significantly at the highest ratio
difference between the two - proved to be a worse chaperone for
yADH (Fig. 7D and E). For both substrates tested D31–35
however showed a consistent enhancement in activity, in a similar
fashion as the D31–40 construct, and is therefore likely the core
region in negatively regulating HSPB6 chaperone activity.
Single point mutations
Since residues 31 to 35 comprise the most conserved part of the
N-terminal domain (Fig. 1A and Fig. S1), we investigated this
region more thoroughly by using single point mutations.
Specifically we focused on Q31 and F33, two residues with large
side chains that are present in almost all sequences examined
(Fig. 1A and Fig. S1). Both positions were mutated to an alanine
(Q31A and F33A) and to an additional amino acid that mimicked
the size of the original amino acid but altered the hydrophobicity
(Q31L and F33Y). The highly conserved glycine G34 was not
included in the mutational analysis, as its achiral centre and lack of
side chain make this residue less amendable for choosing a suitable
substitution.
Analytical SEC experiments showed that both Q31 mutations
had the same non-ideal behavior as seen for the wild-type protein
(Fig. 8A and Table 1). Whereas Q31L had a moderately higher
propensity to self-interact than the wild-type protein (Table 1), the
Q31A showed the presence of a larger species, observed as a
shoulder of the main peak in the elution profile (Fig. 8A). Based on
column calibration this earlier eluting species of Q31A was
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calculated to have double the mass of the principal peak, which
was equivalent to the single peak seen for the wild type. The
position of the maxima of the new peak did not change with
increasing loaded sample concentration, but rather an increase in
relative height when compared to the later eluting species
(Fig. 8A). Thus the Q31A mutant seems to assemble, in a
concentration dependent manner, into what appear to be
tetramers. These latter species themselves behave ideally and
appear to be the upper limit of assembly with no obvious peak
showing a size equivalent of the large oligomers of HSPB1, as seen
for all other constructs (data not shown). In contrast to the Q31
mutants, both F33A and F33Y, showed no or limited self-
association at the various concentrations tested, just like the D31–
35 construct. The data therefore suggest that F33 is the essential
residue in determining the attractive self-interaction of the wild-
type protein, although the residues in the vicinity do appear to
have a role in the potency of such non-ideal behavior.
When examining the SEC-coupled SAXS curves for each
construct they were both similar to that of the wild-type protein
(Fig. 8B and Fig. S4). However, both Q31 mutations show a
bigger Dmax of approximately 130 A˚ compared to 110 A˚ for wild-
type at the same concentration. The polydispersity and associative
behavior of both was further underlined by the calculated Rg
across the peak: for Q31A this ranges from 38 to 35 A˚ and for
Q31L from 39 to 33 A˚. Using the Shodex analytical SEC column,
the SAXS-based elution profile of Q31A only showed a single
peak (Fig. 8B), rather than two peaks seen on the Superdex SEC
column, thus the mixture of tetramers and dimers was not
resolved. Nonetheless, the Rg range of this construct differed from
the wild-type showing a stable plateau at 38 A˚ before the typical
decrease in Rg, likely representing the existence of two species.
Both F33 mutations show a slightly smaller Dmax of 105 A˚ and an
Rg variation across the eluted peak between 30 and 28.5 A˚,
demonstrating the same size and ideal behavior as the D31–35 and
D31–40 constructs (Fig. 8B and Fig. S4).
Bis-ANS binding studies showed minor changes in the overall
hydrophobicity for F33A and F33Y, both with similar fluorescence
curves as the full-length protein (Fig. 8C). The Q31A mutant
demonstrated a slightly lower hydrophobicity, whereas the Q31L
mutant had a slightly higher hydrophobicity compared to full
length HSPB6 (Fig. 8C). The Q31A mutation appears to reach a
plateau, as seen for the D61–70 construct, likely reflecting the
propensity of this mutant to form tetramers that have an apolar
environment with higher affinity for the probe. Again no large
differences, as seen between full-length HSPB6, HSPB1 and
HSPB4 could be observed, indicating overall the small oligomeric
nature of all four HSPB6 mutants.
The chaperoning assays using reduced insulin as a substrate
showed that only the Q31L mutant replicated the enhanced
activity observed for the D31–35 and D31–40 constructs (Fig. 8D
and E). Both Q31A and F33Y resembled the wild type protein,
albeit with slightly diminished activities. Intriguingly, the F33A
mutant proved to be less active at chaperoning at all concentra-
tions tested, showing percentage protection values that were less
than any of the 10 residue deletion constructs (Fig. 6A, B, Fig. S5
and S6). Similarly, the Q31L mutant showed elevated chaperone
activity when tested with yADH. In contrast the three other
mutants were severely hampered in their ability to protect this
substrate from aggregating.
As expected from the previous assays with HEWL, all point
mutations ultimately resulted in higher levels of aggregation (Fig.
S6, G–H). Again, F33A the construct that showed the lowest
protection for insulin and yADH, co-aggregated less with
lysozyme. Surprisingly both substitutions at residue Q31 showed
an increase in the lag phase prior to observable aggregation when
compared to the substrate alone for the highest ratio of
sHSP:substrate tested (Fig. S6, G–H). The Q31L mutant in
particular afforded the most protection, increasing the lag phase
by approximately 15 minutes.
The simultaneous deletion of Q31 and F33 residues in the D31–
35 construct enhanced chaperone-like activity but eliminated the
propensity of HSPB6 to self-associate. The results from the single
residue substitutions suggest that these two properties can be, in
the simplest model, treated independently. Q31 appears to be the
principal residue in regulating chaperone activity, while F33 can
be linked to the association properties (Fig. 9).
Discussion
Human HSPB6 belongs to a small group of sHSPs, including
representatives from bacteria and plants, which appear to only
exist as dimers in solution [25,42,43]. While being distinct with
this respect from prototypical sHSP family members that are
typically found as large homooligomers, these dimeric sHSPs still
demonstrate equivalent chaperone-like activity [42–44]. This
study is the first to apply a systematic approach towards
characterizing the role of the N-terminal domain (NTD) in
defining the chaperoning activity of a human sHSP. In vertebrate
sHSPs this region has been implicated both in higher-order
assembly and chaperoning [19,21,45]. This dual role can thus
complicate interpretation of deletion or mutation analysis due to
possible interfering effects. By using human HSPB6 we were able
Table 3. Size analysis by DLS of aggregated species.
Sample Hydrodynamic radius (nm) Polydispersity
WTa 4.761.7 36.6%
insulin + DTTb 16246989.1 60.9%
insulin + WT (1:0.2)c 27.7614.6 52.5%
insulin + WT (1:0.1)c 138.26100.4 72.6%
insulin + D31–40 (1:0.2)c 23.0612.9 56.3%
insulin + D31–40 (1:0.1)c 57.7642.9 74.4%
aHSPB6 was diluted in buffer to a concentration of 1 mg/ml and the measurement was performed at 35uC.
b0.25 mg/ml of insulin was incubated with 10 mM DTT at 37uC prior to measurement to assure full aggregation.
c0.25 mg/ml insulin was incubated with sHSP in the indicated monomer molar ratio to yield the same concentrations as used for the chaperone assays. This mixture was
incubated with 10 mM DTT at 37uC prior to measurement.
doi:10.1371/journal.pone.0105892.t003
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to examine the role of the NTD of this particular sHSP exclusively
in terms of activity.
Previously we have shown that a number of truncations of the
NTD of HSPB6, identified by limited trypsinolysis, had either
reduced or no chaperone-like activity when using insulin as a
substrate [25]. Expanding on this work we demonstrate here that
the full NTD is essential, as complete removal of this domain
prevents chaperoning of a number of standard substrates. To
further delineate regions important for activity we generated 10-
residue deletion mutants that covered the full N-terminal region of
this sHSP. Analytical SEC and SAXS analyses of the various
constructs clearly showed that small deletions in the NTD had no
profound effect on the structure (Fig. 2–5). As all the deletions
formed dimers in solution, similar to the full-length protein,
changes in chaperone activity can thus be directly related to loss of
a functional sequence rather than any change in the oligomerisa-
tion state.
None of the 10-residue deletions in the NTD resulted in a
complete loss of activity seen for the DN truncation (Fig. 6 and Fig.
S5). This result suggests that there are likely multiple, redundant
substrate binding sites in this region. Even so for all substrates
tested, we observed that removal of residues in the range 41 to 60
limited the chaperoning capacity of HSPB6. We additionally saw
that residues 21–30 may play in role for a subset of the substrates.
A similar redundancy and variability in substrate preference has
also been seen for the NTDs of other sHSPs, including the dimeric
HSP18.1 from Arabidopsis thaliana, suggesting a common
mechanism [42,46].
While the majority of truncations had a negative effect on
chaperone-like activity, we unexpectedly found that deletion of
residues 31–40 resulted in a strong enhancement in the capacity of
HSPB6 to protect a number of substrates from forming large
insoluble aggregates (Fig. 6). Further iterative deletion analysis
pinpointed residues 31–35 as having a role in this phenomenon
(Fig. 7 and Fig. S6). This particular region of the NTD is highly
conserved, being found in five other human sHSP homologues as
well as orthologues in a variety of vertebrate and invertebrate
species (Fig. 1A and Fig. S1). A study where the conserved region
SRLFDQFFG, corresponding to HSPB6 residues 26 to 34, was
deleted in the a-crystallins also yielded an improvement in the
ability to chaperone reduced insulin [47]. This deletion also
resulted in smaller oligomers showing a higher turnover of the
component subunits. In equivalence to these latter effects we also
observed that D31–35 showed no weak self-association, a property
readily detected by SEC with full-length HSPB6 and most other
deletion constructs (Fig. 4 and Table 2). Taken together these
results suggest a dual role of this region, firstly in regulating activity
and secondly in stabilizing interactions between the individual
dimers.
To further delineate the functional residues in the 31–35 region
of HSPB6 we generated mutants of Q31 and F33, the two most
highly conserved residues found present in a large range of sHSP
orthologues (Fig. 1A and Fig. S1). Interestingly, no single
substitution replicated all the biophysical and biochemical
properties of the larger deletions suggesting the studied residues
have different roles. We found that Q31 is important for
chaperoning whilst F33 drives the self-association phenomenon
(Fig. 8A, D and E). Moreover, our results point to an inhibitory
cross-talk between these residues (Fig. 9). Both Q31 mutations
resulted in a higher propensity of the HSPB6 dimers to self-
associate, in particular Q31A resulted in a fraction of higher
molecular weight oligomers, likely tetramers (Fig. 8A and
Table 2). This suggests that Q31 somehow reduces the ‘stickiness’
of F33– possibly because of its polar nature. In contrast, both
substitutions of F33 resulted in a significant reduction in
chaperone activity, lower than any of the larger deletion
constructs, suggesting that this residue limits the ability of Q31
to suppress activity.
Previous studies of the NTD in aB-crystallin also identified
residues F24, F27 and F28 as important. Despite some discrep-
ancies in the results, which could be due to the fact that aB-
Figure 7. Characterization of the D31–35 and D36–40 deletion
constructs of HSPB6. (A) Size-exclusion chromatography profiles,
100 ml of protein was loaded onto a Superdex 200 10/300 GL column at
different concentrations. 2.5 mg/ml is shown as a solid line, 5 mg/ml as
a dashed line and 10 mg/ml as a dotted line. The absorbance was
normalized to the maximum for each curve. (B) SAXS analysis of D31–
35. 250 frames were collected during elution from a Shodex KW-404F
column. The radius of gyration (Rg) and forward scattering (I0) were
calculated at each measured point using buffer subtracted scattering
curves that had been averaged by a ten-frame moving average
algorithm to improve the signal-to-noise. The forward scattering values
are normalized by dividing the values by the concentration of the
sample at the peak maximum. The Rg is plotted as a black cross and
scaled on the left axis, the I0 is shown as a red circle and scaled on the
right axis. (C) Bis-ANS titration curves. 2.5 mM of protein was incubated
with increasing concentrations of bis-ANS and fluorescence intensities
were recorded at 490 nm with an excitation wavelength of 390 nm.
HSPB6 is depicted in yellow, D31–35 in blue and D36–40 in red. (D)
Chaperone-like activity using insulin as a substrate, the monomer mass
molar ratios tested were 1:0.2 (black), 1:0.1 (dark gray) and 1:0.05 (light
gray). (E) Chaperone-like activity using yADH. The ratios used are 1:2
(black), 1:1 (dark gray) and 1:0.5 (light gray).
doi:10.1371/journal.pone.0105892.g007
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crystallin isolated from different mammalian species was used, or
to differences in the assay, all studies showed either a decrease in
activity and oligomeric size or a decreased stability at elevated
temperatures upon mutating one or more of these residues [48–
50]. Interestingly, the mutation of F28 in bovine aB-crystallin,
which is equivalent to F33 in HSPB6 (Fig. 1A), showed decreased
chaperone activity and a smaller oligomeric size at elevated
temperatures [49], both properties similar to the behavior of our
F33 mutants of HSPB6. A recent paper on the structure of
Hsp16.0 from a fission yeast also pointed out an important role for
phenylalanines in the N-terminal domain in allowing oligomer
formation and chaperone-activity. In particular mutation of either
F6 or F7 in this protein led to impaired chaperone function as well
as disassembly of the oligomers [51] and suggests a conserved role
for phenylalanines even in distantly related species.
In summary, we have extensively mapped the N-terminal
domain of HSPB6, and could delineate two regions of particular
functional importance. Firstly, the region between residues 41 and
60 seems to be necessary for chaperoning, as determined by light
scattering using two different substrates. Secondly, we show that
Figure 8. Characterization of the HSPB6 point mutations. (A) Size-exclusion chromatography profiles. 100 ml of protein was loaded onto a
Superdex 200 10/300 GL column at different concentrations. 2.5 mg/ml is depicted as a full line, 5 mg/ml as a dashed line and 10 mg/ml as a dotted
line. The absorbance was normalized to the maximum absorbance for each curve. (B) SAXS analysis of the HSPB6 mutants. For each construct, 250
frames were collected during elution from a Shodex KW-404F column. The radius of gyration (Rg) and forward scattering (I0) were calculated at each
measured point using buffer subtracted scattering curves that had been averaged by a ten-frame moving average algorithm to improve the signal-
to-noise. The forward scattering values are normalized by dividing the values by the concentration of the sample at the peak maximum. The Rg is
plotted as a black cross for each construct and scaled on the left axis, the I0 is shown as a red circle and scaled on the right axis. (C) Bis-ANS titration
curves, 2.5 mM protein was mixed with increasing concentrations of bis-ANS and fluorescence intensities were measured at 490 nm using and
excitation wavelength of 390 nm. Wild type B6 is shown in yellow, Q31A in red, Q31L in green, F33A in blue and F33Y in pink. (D) Chaperone-like
activity of wild-type HSPB6 and its mutants against aggregating insulin, the monomer mass molar ratios tested were 1:0.2 (black), 1:0.1 (dark gray)
and 1:0.05 (light gray). (E) Chaperone-like activity of wild type B6 and its mutants against aggregating yADH. The ratios used are 1:2 (black), 1:1 (dark
gray) and 1:0.5 (light gray).
doi:10.1371/journal.pone.0105892.g008
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the highly conserved region (residues 26 to 34) includes residues
responsible for the negative regulation of activity. Such repression
may have a role in limiting sHSPs from aberrantly binding
proteins which would have a detrimental effect on proteostasis.
This study is the first full analysis, combining truncations and
mutations, which confirms the importance of this region of the
NTD that is conserved across different vertebrate sHSPs, and can
serve as a reference for further analyses in other mammalian
sHSPs. This may be particularly pertinent for understanding the
activity of the disassociated species of oligomeric sHSPs, for
example in the case of HSPB1 (HSP27) where phosphorylation
changes the equilibrium of assembly association, biasing towards
the presence of chaperone competent dimers [52].
This study also illustrates the complexity of the NTD
interactions involved, as evidenced by the counter-intuitive results
observed for the single residue mutations versus the larger
deletions. Additionally the nature of the residue substitutions at
one site had quite differing effects, where Q31L afforded the most
protection to the substrates, possibly due to replacement of this
polar residue by a more hydrophobic one, and Q31A had wild-
type chaperone-like activity. Combined our results suggest that
mutational studies of members of this chaperone family should be
viewed with extra caution, as single site mutations may lead to
conflicting conclusions due to a lack of understanding of the role
that surrounding residues play on structure and function.
Supporting Information
Figure S1 Multiple alignment of the N-terminal domain of
sHSPs from different vertebrate species. Sequences of the N-
terminal domain of human HSPB1, HSPB4, HSPB5, HSPB6 and
HSPB8 were aligned against their orthologues found in bovine,
rodent, Xenopus and zebrafish with Muscle [56]. Using Jalview
[57] the aligned sequences were grouped based on their UniProt
annotation and each group was colored using the ClustalX
scheme. The conserved sequence, found present in all represen-
tative sHSPs, is highlighted beneath the alignment with a red line.
(TIF)
Figure S2 SDS-PAGE analysis of all HSPB6 constructs. Equal
amounts of each purified protein were loaded on a 15%
polyacrylamide gel alongside the PageRuler prestained protein
ladder (Thermo Scientific). The gel was stained with Coomassie
Brilliant Blue R-250.
(TIF)
Figure S3 SAXS data for all HSPB6 10-residue deletions. For
all constructs the averaged scattering curve (black circles)
overlayed with the regularized curve calculated from the pair-
distribution function (red line), the pair-distribution function and
the dimensionless Kratky plot is shown (from top to bottom,
respectively). For each protein ten scattering curves around the
elution maxima were scaled to the curve with the highest I0 and
averaged using PRIMUS [58]. The intraparticle distance
distribution function was solved using GNOM [59] incorporating
the averaged scattering curve data up to q = 0.3 A˚21. The
dimensionless Kratky plot of the averaged scattering data (blue
circles) was generated using the reciprocal space Rg and I0 values
calculated with GNOM. For reference the Guinier approximation
of a spherical particle at low angles is shown as a black line using
the function f(x) = x2*exp(2x2/3).
(TIF)
Figure S4 SAXS data for D31–35 and the single site point
mutations of HSPB6. For all constructs the averaged scattering
curve (black circle) overlayed with the regularized curve calculated
from the pair-distribution function (red line), the pair-distribution
function and the dimensionless Kratky plot is shown (from top to
bottom, respectively). For each protein ten scattering curves
around the elution maxima were scaled to the curve with the
highest I0 and averaged using PRIMUS [58]. The intraparticle
distance distribution function was solved using GNOM [59]
incorporating the averaged scattering curve data up to q = 0.3
A˚21. The dimensionless Kratky plot of the averaged scattering
data (blue circles) was generated using the reciprocal space Rg and
I0 values calculated with GNOM. For reference the Guinier
approximation of a spherical particle at low angles is shown as a
black line using the function f(x) = x2*exp(2x2/3).
(TIF)
Figure S5 Chaperone activity of wild type HSPB6 and its
truncations. 0.25 mg/ml of insulin (panels A–C), yADH (panels
D–F) or HEWL (G–I) were incubated with HSPB6 and the 10
amino acid deletions in different ratios. Aggregation was induced
Figure 9. Cartoon summarizing the interplay between Q31 and F33 in defining the properties of HSPB6.
doi:10.1371/journal.pone.0105892.g009
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by adding 10 mM DTT (final) for insulin and HEWL at 37uC or
20 mM DTT and 2 mM EDTA at 42uC for yADH. The
absorbance at 340 nm was monitored for 90 min with a
measurement every minute. For clarity, 5 points have been
skipped for each curve. For insulin the ratios were (A) 1:0.2; (B)
1:0.1; (C) 1:0.05. For yADH (D–F) and HEWL (G–I) the ratios
were (D and G) 1:2 ratio; (E and H) 1:1 ratio; (F and I) 1:0.5 ratio.
Panels J and K represent the stability of B6 and the deletions at
37uC (J) and 42uC (K) under the same buffer conditions as used for
the assay, the control experiment for DN is shown in dark gray
with open triangles. For all plots, substrate alone is colored in
black, substrate + DTT in grey, HSPB6 in yellow, DN11 in blue,
D11–20 in cyan, D21–30 in red, D31–40 in green, D41–50 in
orange, D51–60 in pink and D61–70 in violet.
(TIF)
Figure S6 Chaperone activity of wild type B6, D31–35, D36–40
and the point mutations. 0.25 mg/ml of insulin (panels A–C),
yADH (panels D–F) or HEWL (G–I) were incubated with HSPB6
and its mutants in different ratios. Aggregation was induced by
adding 10 mM DTT (final) for insulin and HEWL at 37uC or
20 mM DTT and 2 mM EDTA at 42uC for yADH. The
absorbance at 340 nm was monitored for 90 min with a
measurement every minute. For clarity, 5 points have been
skipped for each curve. For insulin the ratios were (A) 1:0.2; (B)
1:0.1; (C) 1:0.05. For yADH (D–F) and HEWL (G–I) the ratios
were (D and G) 1:2 ratio; (E and H) 1:1 ratio; (F and I) 1:0.5 ratio.
Panels J and K represent the stability of B6 and the mutations at
37uC (J) and 42uC (K) under the same buffer conditions as used for
the assay. For all plots, substrate alone is colored in black, substrate
+ DTT in grey, HSPB6 in yellow, D31–35 in blue, D36–40 in
cyan, Q31A in red, Q31L in green, F33A in orange and F33Y in
pink.
(TIF)
Table S1 Primers used in this work. All PCR-reactions were set
up with pETHSUL-HSPB6 [55] as a template.
(PDF)
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